While the relationship between circulating EGFR and APOA1 levels and tumor cell growth remains complex and controversial, this differential alteration in EGFR and APOA1 levels may be associated with the observed inhibition of proliferation in the cultured HepG2 cells treated with these serum samples. This evidence concerns the gene EGFR and neoplasm.